HPS Pharmacies wish to give notice that Aspen Pharmacare Australia Pty Ltd is continuing to experience a supply interruption for local anaesthetic products.

The following non-autoclaved products are now available, as follows:

Product ARTG Current Status
Marcain 0.25% with Adrenaline 5x20mL 125878 In stock – short dated
Marcain 0.5% with Adrenaline 5x20mL 48329 In stock – short dated / constrained supply
Xylocaine 1% with Adrenaline 5x20mL 12015 In stock – short dated
Xylocaine 2% with Adrenaline 5x20mL 12021 In stock – short dated

Aspen has now received approval from the Therapeutic Goods Administration (TGA) to allow the sterilisation process to be carried out on their products. Distribution of the following Sterile Theatre Packs is expected to resume, as follows:

Product ARTG Current Status
Marcain 0.25% with Adrenaline 1:400,000 5x20mL (theatre pack) 125878 Quarter 3, 2023
Marcain 0.5% with Adrenaline 1:200,000 5x20mL (theatre pack) 48329 Quarter 3, 2023
Xylocaine 2% Adrenaline 1:200,000 5X20mL (theatre pack) 12021 Quarter 3, 2023
Xylocaine 1% Adrenaline 1:200,000 5X20mL (theatre pack) 12015 Quarter 3, 2023
Xylocaine 0.5% Adrenaline 1:200,000 5X20mL (theatre pack) 12008 Quarter 3, 2023

In addition, normal supplies of Citanest 0.5% (prilocaine hydrochloride 250mg/50mL) vials are expected to return in late April to early May 2023. All other Aspen local anaesthetic products are available.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare Australia on 1300 659 646.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates